Welcome to our dedicated page for Thermo Fisher Scientific news (Ticker: TMO), a resource for investors and traders seeking the latest updates and insights on Thermo Fisher Scientific stock.
Thermo Fisher Scientific, Inc. (TMO) is a global leader in providing science-based solutions, offering a wide range of products and services in the life sciences, analytical instruments, specialty diagnostics, and laboratory products sectors. The company's expansive portfolio includes scientific instruments, laboratory equipment, diagnostic consumables, and life science reagents, serving customers both in the United States and internationally.
Thermo Fisher operates through four distinct segments as of end-2023:
- Analytical Technologies (17% of sales): This segment focuses on providing high-quality instruments and software solutions for various scientific applications.
- Specialty Diagnostic Products (10% of sales): This segment specializes in offering diagnostic reagents and instruments for medical and research laboratories.
- Life Science Solutions (23% of sales): This segment provides reagents, instruments, and consumables used in biological research and drug development.
- Lab Products and Services (54% of sales): This is the largest segment, encompassing laboratory supplies, equipment, and contract research organization (CRO) services.
Thermo Fisher is continually expanding its offerings and capabilities through strategic partnerships, acquisitions, and technological innovation. The company's robust financial performance underscores its leadership in the industry, driven by consistent revenue growth, strong market presence, and a commitment to advancing scientific research and healthcare.
Recent achievements include technological advancements in analytical instruments, enhanced diagnostic solutions, and expanded biopharma services, reflecting Thermo Fisher's dedication to supporting life-saving research and diagnostic processes. Thermo Fisher remains committed to delivering high-quality products and services, fostering scientific breakthroughs, and maintaining its position at the forefront of scientific innovation.
Rhea-AI Summary
Thermo Fisher Scientific Inc. reported strong financial results for the first quarter of 2024, with revenues of $10.34 billion. The company saw a 4% increase in GAAP diluted EPS and a 2% increase in adjusted EPS. Thermo Fisher launched innovative new products, expanded its services, and collaborated with customers to develop companion diagnostics. The company also repurchased $3.0 billion of stock and increased its dividend by 11%. Despite a 3% decline in revenue, Thermo Fisher raised its full-year revenue and adjusted EPS guidance for 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.49%
Tags
-
Rhea-AI Summary
Thermo Fisher Scientific Inc. (TMO) will release its Q1 2024 financial results on April 24, 2024, followed by a conference call to discuss financial performance and future expectations. Investors can access the call via phone or the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.02%
Tags
-
Rhea-AI Summary
Thermo Fisher Scientific Inc. extends the expiration time of the tender offer to acquire Olink Holding AB for $26.00 per Share and per ADS, in cash. Approximately 95.2% of outstanding Shares have been tendered. Completion of the Offer is subject to SEC conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.08%
Tags
News
Rhea-AI Summary
Thermo Fisher Scientific Inc. (TMO) CEO to present at TD Cowen Health Care Conference on March 6, 2024. Webcast available on the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.04%
Tags
-
Rhea-AI Summary
Thermo Fisher Scientific Inc. (TMO) increases quarterly dividend by 11% to $0.39 per share, payable on April 15, 2024, to shareholders of record as of March 15, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.38%
Tags
-
Rhea-AI Summary
Thermo Fisher Scientific Inc. (TMO) reported Q4 revenue of $10.89 billion, 5% lower than the previous year. Full-year revenue was $42.86 billion, also 5% lower. GAAP diluted EPS for Q4 was $4.20, 5% higher than last year, with an adjusted EPS of $5.67, also 5% higher. The company strengthened its industry leadership, launched innovative products, and expanded its global presence. Thermo Fisher executed its capital deployment strategy, completed key acquisitions, and returned $3.5 billion to shareholders. The company initiated a guidance range for full year 2024 with revenue of $42.1 billion to $43.3 billion and adjusted EPS of $20.95 to $22.00.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.29%
Tags
Rhea-AI Summary
Thermo Fisher Scientific Inc. (NYSE: TMO) has extended the expiration time of the offering period to acquire all outstanding common shares and American Depositary Shares of Olink Holding AB (publ) for $26.00 per Share and per ADS, in cash. Approximately 94.1% of the outstanding Shares have been tendered and not properly withdrawn pursuant to the Offer.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.61%
Tags
-
Rhea-AI Summary
Thermo Fisher Scientific Inc. (NYSE: TMO) to Present at 42nd Annual J.P. Morgan Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.82%
Tags
-
Rhea-AI Summary
Thermo Fisher Scientific Inc. (NYSE: TMO) will release its Q4 and full year 2023 financial results on January 31, 2024, followed by a conference call to discuss its financial performance and future expectations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.52%
Tags
Rhea-AI Summary
Thermo Fisher Scientific, Inc. (TMO) was awarded the SBER Outstanding Leader of 2023. Debra Pulpi at Teradyne, Inc. (TER) received the SBER Outstanding Executive of 2023. PTC, Inc. (PTC) was named the SBER Most Improved Corporate Leader of 2023. These awards were presented by Sustainability Roundtable, Inc. (SR Inc) at its Year-End Executive Symposium in Washington D.C. Thermo Fisher was recognized for its leadership in renewable energy and corporate sustainability, Teradyne for its data-driven approach to renewable energy strategy, and PTC for impressive strides in environmental sustainability.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.08%
Tags
FAQ
What is the current stock price of Thermo Fisher Scientific (TMO)?
The current stock price of Thermo Fisher Scientific (TMO) is $513.08 as of November 15, 2024.
What is the market cap of Thermo Fisher Scientific (TMO)?
The market cap of Thermo Fisher Scientific (TMO) is approximately 196.7B.
What does Thermo Fisher Scientific, Inc. specialize in?
Thermo Fisher Scientific specializes in life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services.
What are the main segments of Thermo Fisher Scientific?
The main segments are Analytical Technologies, Specialty Diagnostic Products, Life Science Solutions, and Lab Products and Services.
How much of Thermo Fisher's sales come from Lab Products and Services?
Lab Products and Services account for 54% of Thermo Fisher's sales.
Where does Thermo Fisher Scientific operate?
Thermo Fisher Scientific operates both in the United States and internationally.
What recent achievements has Thermo Fisher Scientific made?
Recent achievements include advancements in analytical instruments, enhanced diagnostic solutions, and expanded biopharma services.
What is Thermo Fisher Scientific's stock symbol?
The stock symbol for Thermo Fisher Scientific is TMO.
How does Thermo Fisher Scientific support scientific research?
Thermo Fisher supports scientific research by providing high-quality instruments, reagents, and consumables essential for biological research and drug development.
What types of products does Thermo Fisher Scientific offer?
Thermo Fisher offers scientific instruments, laboratory equipment, diagnostic consumables, and life science reagents.
What is Thermo Fisher's commitment to the healthcare industry?
Thermo Fisher is committed to advancing scientific research and healthcare by delivering high-quality products, fostering scientific breakthroughs, and supporting life-saving research and diagnostic processes.
What sets Thermo Fisher Scientific apart in its industry?
Thermo Fisher's leadership stems from its diverse portfolio, strategic partnerships, technological innovation, and consistent financial performance.
Thermo Fisher Scientific, Inc.
NYSE:TMO
TMO Rankings
TMO Stock Data
196.72B
382.50M
0.18%
91.37%
0.8%
Diagnostics & Research
Measuring & Controlling Devices, Nec
United States of America
WALTHAM